As of 2025-05-15, the Relative Valuation of CannaPharmaRx Inc (CPMD) is 0.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of CannaPharmaRx Inc based on Relative Valuation is 410.1%.
The range of the Relative Valuation is 0.01 - 0.04 USD.
| Range | Selected | |
| Trailing P/E multiples | 2.6x - 5.7x | 4.2x |
| Forward P/E multiples | 2.6x - 6.3x | 4.4x |
| Fair Price | 0.01 - 0.04 | 0.02 |
| Upside | 65.4% - 980.3% | 410.1% |
| Date | P/E |
| 2025-05-13 | 1.58 |
| 2025-05-12 | 1.58 |
| 2025-05-09 | 1.58 |
| 2025-05-08 | 1.49 |
| 2025-05-07 | 1.63 |
| 2025-05-06 | 1.54 |
| 2025-05-05 | 1.68 |
| 2025-05-02 | 2.11 |
| 2025-05-01 | 1.68 |
| 2025-04-28 | 2.11 |
| 2025-04-25 | 2.11 |
| 2025-04-24 | 2.11 |
| 2025-04-22 | 2.11 |
| 2025-04-17 | 2.11 |
| 2025-04-16 | 2.16 |
| 2025-04-09 | 2.64 |
| 2025-04-08 | 2.64 |
| 2025-04-07 | 2.11 |
| 2025-04-04 | 2.21 |
| 2025-04-03 | 2.16 |
| 2025-04-01 | 2.30 |
| 2025-03-31 | 1.92 |
| 2025-03-28 | 1.92 |
| 2025-03-27 | 1.92 |
| 2025-03-26 | 1.92 |
| 2025-03-24 | 1.92 |
| 2025-03-21 | 1.92 |
| 2025-03-20 | 2.64 |
| 2025-03-19 | 2.64 |
| 2025-03-14 | 2.64 |
| 2025-03-11 | 2.64 |
| 2025-03-10 | 2.64 |
| 2025-03-07 | 2.64 |
| 2025-03-06 | 1.73 |
| 2025-03-04 | 2.69 |
| 2025-03-03 | 3.07 |
| 2025-02-28 | 1.92 |
| 2025-02-26 | 3.36 |
| 2025-02-25 | 3.36 |
| 2025-02-24 | 3.36 |
| 2025-02-20 | 3.36 |
| 2025-02-19 | 3.12 |
| 2025-02-18 | 2.88 |